That FDA action closing down Iclusig was irresponsible. The possible corrections (lower dose, possible patient screening, statins etc) could have been made without destroying Iclusig's reputation.
Now Ariad has to use its assets to defend the SE arguments instead of furthering trials that could be helping desperate patients. It cost Ariad probably two full years of drug development and the opportunity to fund them.
I hate to dwell on the thought that some sinister plot was behind all this, but it does stick in my craw.
That said, go HB, Denner, Blackrock !!
